Memorial Sloan Kettering Cancer Center

Oncologic Toxicity Management Symposium 2025

Novel Oncology Agents & Adverse Events – On Demand

📦 Product Details

• Format: On-Demand Recorded Symposium
• Recording Date: June 20, 2025
• Access Period: Oct 11, 2025 – Apr 30, 2026
• Level: Advanced Oncology Update
• Focus: Cancer therapeutics & toxicity management

🧬 Program Overview

The MSKCC Oncologic Toxicity Management Symposium 2025 delivers a comprehensive, evidence-based update on next-generation cancer therapies and their associated toxicities.

As oncology rapidly evolves, novel treatments such as immunotherapy, targeted therapy, and cellular therapy are transforming patient outcomes—but also introducing complex adverse events.

This program equips clinicians with the knowledge to recognize, prevent, and manage treatment-related toxicities, ensuring safer and more effective patient care.

🎯 Key Features

• Expert-led sessions from leading oncology specialists
• Focus on cutting-edge cancer therapies
• Emphasis on real-world toxicity management
• Case-based discussions and clinical insights
• Multidisciplinary approach across oncology subspecialties

📚 What You Will Learn

• Mechanisms and clinical applications of modern oncology agents
• Early recognition of treatment-related adverse events
• Evidence-based strategies for toxicity prevention and management
• Management of immune-related and organ-specific toxicities
• Balancing treatment efficacy with patient safety

🧩 Core Topics Covered

🎯 Radioligand Therapy

• Targeted radiation delivery to tumor cells
• Clinical applications and effectiveness
• Management of radiation-related toxicity

💊 Antibody-Drug Conjugates (ADCs)

• Precision chemotherapy delivery systems
• Clinical benefits and emerging agents
• Toxicity profiles and management strategies

🧫 CAR-T Cell Therapy

• Mechanism and clinical use
• Cytokine Release Syndrome (CRS)
• Neurotoxicity (ICANS) management

🔗 Bispecific Antibodies

• T-cell redirection strategies
• Clinical applications in oncology
• Immune-related toxicity management

⚙️ Small Molecule Inhibitors (SMIs)

• Targeted pathway inhibition
• Cardiovascular and metabolic adverse effects
• Risk mitigation strategies

🛡️ Immune Checkpoint Inhibitors (ICIs)

• Mechanism of action in cancer therapy
• Immune-related adverse events (irAEs)
• Organ-specific toxicity management

🧠 Learning Approach

• Evidence-based lectures
• Clinical case discussions
• Practical toxicity management strategies
• Real-world oncology scenarios

👨‍⚕️ Target Audience

• Medical oncologists
• Hematologists
• Oncology fellows and trainees
• Nurse practitioners & physician assistants
• Pharmacists and researchers
• Multidisciplinary cancer care teams

🌐 Covered Specialties

• Medical Oncology & Immunotherapy
• Cardiology (cardio-oncology)
• Dermatology & Dermatopathology
• Neurology & Neuro-oncology
• Endocrinology & Metabolism
• Gastroenterology & GI Oncology
• Rheumatology & Immunology

🚀 Why This Course Stands Out

• Focused on modern oncology therapies (2025 updates)
• Strong emphasis on toxicity recognition and management
• Covers high-impact therapies used in daily practice
• Delivered by experts from MSKCC – a global oncology leader
• Essential for clinicians managing complex cancer treatments